By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
AmextaFinanceAmextaFinance
  • Home
  • News
  • Banking
  • Credit Cards
  • Loans
  • Mortgage
  • Investing
  • Markets
    • Stocks
    • Commodities
    • Crypto
    • Forex
  • Videos
  • More
    • Finance
    • Dept Management
    • Small Business
Notification Show More
Aa
AmextaFinanceAmextaFinance
Aa
  • Banking
  • Credit Cards
  • Loans
  • Dept Management
  • Mortgage
  • Markets
  • Investing
  • Small Business
  • Videos
  • Home
  • News
  • Banking
  • Credit Cards
  • Loans
  • Mortgage
  • Investing
  • Markets
    • Stocks
    • Commodities
    • Crypto
    • Forex
  • Videos
  • More
    • Finance
    • Dept Management
    • Small Business
Follow US
AmextaFinance > Investing > This Epidemiologist Has a Plan to Win Back Public Trust After Covid
Investing

This Epidemiologist Has a Plan to Win Back Public Trust After Covid

News Room
Last updated: 2024/01/28 at 10:36 PM
By News Room
Share
7 Min Read
SHARE

The Covid-19 pandemic delivered a blow to the public health system, both through the physical and emotional toll it took on those affected, and through the intense politics that accompanied the disease. Dr. Sandro Galea, epidemiologist and dean at Boston University School of Public Health, writes about what went wrong in his new book, Within Reason: A Liberal Public Health for an Illiberal Time.

In this week’s book Q&A, Dr. Galea talks about how to fix public health’s trust problems and how ready we are for the world’s next big disease. The following transcript has been edited.

Barron’s: Your book revisits the distrust toward public health messaging during the Covid-19 pandemic. What went wrong there?

Sandro Galea: No. 1, we [public health professionals] miscalibrated in terms of how confident we were in our messaging. It’s a concept that I’ve used before, the term “false certitude.” We portrayed confidence when we should not have had as much. In the context of a rapidly evolving pandemic that became problematic because then it seems like we’re changing our mind. 

No. 2, the medium of communication—social media, which took over the Covid narrative—was such that it made it difficult to convey complexity. As a result it accentuated the false certitude. 

No. 3, we were communicating in a time of enormous crosscurrents and political tides, and as a result, it created a confrontational aspect to our messaging that did not allow us to reach people who might feel differently about the approaches to Covid.

Covid is surging right now, but restrictions are limited. Is that another failure of public health?

No, the Covid surge right now is not accompanied by disease with significant morbidity or mortality. So the fact that we have a surge does not necessarily need to be accompanied by restrictions. It simply means that we are adjusting well to Covid becoming a common part of how we do what we do. I do think that our approach right now is probably rational given the stage we’re at with the coronavirus that has become part of our environment.

How do other illnesses such as RSV and the flu fit into this picture?

One of the challenges that we had with Covid was that we over-focused on Covid. As a result, we did not have space to talk about viruses like RSV and the flu, and things like drug overdoses and car accidents. When one focuses so narrowly on one disease, one does not pay attention to other diseases that are equally creating health problems for society. We’re now at a phase where we need to integrate our thinking about Covid with our thinking about other diseases. It’s the collective of those that ultimately shape our health.

The World Health Organization and others have been discussing the idea of preparing for a hypothetical “Disease X,” which would be worse than Covid. Is the public health system ready for a scenario like that?

I don’t think so. We have systematically underinvested in public health as a country and as a world over the past 20 years. A bunch of what happened in Covid was due to the fact that our public health system was ill prepared. So it will require substantially more effort to prepare our public health system for a new Disease X.

What steps should be taken to prepare?

First of all we need to invest. In this country, just to focus on the U.S., most states spend less than $100 per person per year on public health. Most states have had a decrease in the number of people working in public health. Less than 3% of our health expenditure is actually in public health. We spend 97% of our health expenditure on medicine, which is treating people once they’re already sick. But we forget that our goal should be to keep you from getting sick to begin with.

How can public health officials win back public trust?

The key thing that we need to accept is that people can handle uncertainty. One of things that we did [during the pandemic] was we did not trust that people could handle doubt. We [need to] communicate with humility and convey when it is that we know something and when it is that we don’t. In the context of a new disease and a rapidly evolving pandemic, there was much more that we did not know. 

The other element of this is getting better at navigating and learning how to use social media. Social media is a very particular medium of communication. It relies on people who are prominent in social media, relies on communicating in short bursts, relies on the engagement of a broad range of people, which is different than things like television and newspapers. Our established public health sector was not prepared to communicate that way.

Are we in a good place with vaccinations now?

I think the Covid vaccine and boosters will become part of the routine annual boosters that we get for any number of viruses, and that’s appropriate. These [boosters] typically have fairly low uptake every year and in part that’s because people do not see their value. I would like us to focus less on the Covid vaccine and more on just building trust for public health messaging, which will then spill over and serve us well in public health across the board.

Thanks, Dr. Galea.

Write to Stevie Rosignol-Cortez at [email protected]

Read the full article here

News Room January 28, 2024 January 28, 2024
Share this Article
Facebook Twitter Copy Link Print
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Finance Weekly Newsletter

Join now for the latest news, tips, and analysis about personal finance, credit cards, dept management, and many more from our experts.
Join Now
Trump’s immigration data dragnet

“I’ve seen the apps and I don’t like them,” says a DHS…

Why Investors Think Loans Are About To Get Cheaper

Watch full video on YouTube

Bitcoin’s slide signals a warning for equities, Apple reportedly ramps up Tim Cook succession plans

Watch full video on YouTube

Gold’s Bull Run To Continue In 2026

By Ewa Manthey, Commodities Strategist Gold staged a record-breaking rally in 2025,…

Investors should look to the data, rather than the Fed, for guidance

Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects…

- Advertisement -
Ad imageAd image

You Might Also Like

Investing

Why Home Builders Are Bouncing Today—and Why Their Stocks Are Good Buys

By News Room
Investing

This Beaten-Down Industrial Stock Wants to Call America Home. Why It’s Time to Buy.

By News Room
Investing

These 8 Dividend Aristocrats Can Protect Your Portfolio in a Downturn

By News Room
Investing

Some Lenders Benefit From SBA’s Troubled Loan Program

By News Room
Investing

Social Security Is in Turmoil. Should You Lock In Benefits Now?

By News Room
Investing

Hims & Hers Stock Is Due for a Crash Diet. The GLP-1 Surge Is Fading Fast.

By News Room
Investing

Opinion: The stock-market selloff isn’t over yet. Here are 4 reasons why.

By News Room
Investing

With Trump’s tariffs paused, ‘Big Three’ automakers may race to build inventories

By News Room
Facebook Twitter Pinterest Youtube Instagram
Company
  • Privacy Policy
  • Terms & Conditions
  • Press Release
  • Contact
  • Advertisement
More Info
  • Newsletter
  • Market Data
  • Credit Cards
  • Videos

Sign Up For Free

Subscribe to our newsletter and don't miss out on our programs, webinars and trainings.

I have read and agree to the terms & conditions
Join Community

2023 © Indepta.com. All Rights Reserved.

YOUR EMAIL HAS BEEN CONFIRMED.
THANK YOU!

Welcome Back!

Sign in to your account

Lost your password?